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Abstract: L-selectin is a cell adhesion molecule, which mediates leukocyte rolling on 
  bronchopulmonary endothelium. Previous studies in a murine model of allergic airways   disease 
have shown that L-selectin plays a role in the regulation of airway hyperresponsiveness in 
asthma via mechanisms independent of inflammation. Airway remodeling has been shown to 
modulate airway hyperresponsiveness independently of inflammation.
Purpose: Our aim was to determine if L-selectin influenced airway hyperresponsiveness via 
modulation of structural changes as a result of airway remodeling.
Method: A chronic ovalbumin-induced allergic airways disease model was applied to L-  selectin-
deficient mice and wild-type control mice. The development of airway inflammation was 
assessed by examining leukocyte influx into bronchoalveolar lavage fluid. Airway remodeling 
changes were determined via histology and morphometric analysis of lung tissue sections, and 
the development of airway hyperresponsiveness was assessed by invasive plethysmography.
Results: Total cell counts, but not individual differential cell counts, were reduced in 
the ovalbumin-treated L-selectin-deficient mice compared to wildtype ovalbumin-treated mice. 
L-selectin-deficient mice had significantly reduced epithelial thickness and smooth muscle 
thickness. Airway hyperresponsiveness was abrogated in ovalbumin treated L-selectin-deficient 
mice compared to wild-type controls.
Conclusion: L-selectin plays an important role in regulating airway remodeling in an animal 
model of chronic allergic airways disease. Abrogated airway hyperresponsiveness may be related 
to reduced remodeling changes in L-selectin-deficient mice. L-selectin represents a potential 
target for novel asthma treatment for airway remodeling and airway hyperresponsiveness.
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Introduction
Three of the most important components of asthma are airway inflammation 
(  characterized by eosinophils, Th2 lymphocytes, mast cells in the airways), 
airway hyperresponsiveness (AHR; increased reactivity to a bronchoconstric-
tor), and airway remodeling (structural changes contributing to a thickened 
hypersecretory bronchial wall). These three components are associated with 
asthma severity, are interrelated, and may drive each other.1 A treatment capable 
of resolving all three has not yet been identified. The prevalence of asthma 
remains high and a subset of patients remains symptomatic despite maximal 
treatment with current therapies.2
L-selectin (CD62L) is expressed on all leukocytes and is a member of a glyco-
protein family of selectin adhesion molecules including E-, P- and L-selectin.3 The Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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selectins are required for leucocyte tethering and rolling 
on vascular endothelium, important early events in the 
process of extravasation and therefore in the development 
of airway inflammation.3 L-selectin levels in serum have 
been reported to be increased in asthma.4 Selectins bind to 
oligosaccharides that decorate mucin-like glycoproteins on 
the surface of endothelial cells. It is has been suggested that 
blocking this interaction may be useful in developing new 
asthma therapies.5,6
In order to explore the functions of L-selectin, a mouse 
deficient in the protein was created by Arbones et al.7 These 
mice have significantly impaired migration of monocytes, 
lymphocytes and neutrophils to the inflamed peritoneum 
and show high resistance to lipopolysaccharide-induced 
toxic shock.8 In our previous experiments we have exam-
ined the role of L-selectin in the allergic inflammatory 
responses using an animal model of allergic airways disease 
(AAD). We found that migration of activated lymphocytes 
into inflamed lung was inhibited by 30% in the absence of 
L-selectin.9
To investigate the role of L-selectin in airway 
  inflammation and AHR, we previously applied an 
acute ovalbumin (OVA) model of AAD to L-selectin-
deficient mice and C57 black 6 (C57Bl/6) controls.10 We 
found that inflammation was equivalent in L-selectin-
deficient and wild-type mice in both OVA and saline 
treatments, as assessed by total and differential cell 
counts in bronchoalveolar lavage (BAL) and analysis of 
hematoxylin and eosin (H and E) stains of lung tissue. 
However, L-selectin-deficient mice had   significantly 
reduced CD3+ and increased B220+ populations of 
  lymphocytes in the BAL fluid. Despite similar inflam-
matory responses (including eosinophils, neutrophils, 
lymphocytes and monocytes) in the L-selectin-deficient 
mice and controls, L-selectin-deficient mice had abro-
gated AHR.
Airway remodeling may have considerable undesirable 
effects on AHR. It may decrease the ability of the airway 
to respond to bronchodilators.11 Thickening of the airway 
smooth muscle layer,12 as well as thickening of the tissue 
of the luminal and adventitial sides of the airway smooth 
muscle layer, have been predicted to contribute to airway 
narrowing.13–16
To  examine  whether  L-selectin  may  modulate 
  remodeling changes and thereby modulate AHR, we 
applied a chronic model of AAD to mice deficient in 
L-selectin. In this model, OVA-sensitised mice develop 
goblet cell   hyperplasia,   thickening of the reticular 
basement membrane and   submucosa, and increased total 
lung collagen,17 as well as increased AHR, none of which 
are observed in short term acute models.18 The aim of the 
current study, therefore, was to determine the effect of 
L-selectin deficiency on airway remodeling changes in 
a mouse model of chronic AAD in L-selectin-deficient 
mice.
Material and methods
Mice
Female mice deficient in L-selectin were generated as 
  previously described.7 As chronic OVA-induced models 
of AAD have been shown to work optimally in the Balb/c 
strain,19 mice were backcrossed for at least ten generations 
onto a Balb/c background. Age matched wildtype female 
Balb/c mice obtained from the colony of the Murdoch 
  Children’s Research Institute were used as controls.   Animals 
were maintained in a specific pathogen free housing facility. 
All experimental procedures were approved by the Animal 
Ethics Committee of the Royal Children’s Hospital.
chronic mouse model  
of allergic airways disease
An established model of OVA-induced chronic AAD was 
used according to the sensitisation and challenge protocol 
first described by Temelkovski and colleagues (1998) and 
further characterized by our research group.18–20 Briefly, 
6–8 week old mice were sensitised via intraperitoneal 
  injection on day 0 and day 14 with 10 µg of grade V chicken 
OVA (Sigma chemical, St. Louis, Missouri, USA) and 1 mg 
of aluminium potassium sulfate (alum) adjuvant in 500 µl 
saline (Sigma Chemical, St. Louis, Missouri, USA). Mice 
were then   challenged with nebulised 2.5% (w/v) OVA in 
saline solution using an ultrasonic nebulizer (NE-U07; 
Omron Corporation, Tokyo, Japan) for 30 minutes, 3 days 
per week for 6 weeks, from day 21 to 63. The ultrasonic 
nebulizer delivered an output of 1 mL/min and 1 µm to 
5 µm particle size. Control mice received an equal quantity 
of alum in 500 µL of saline via intraperitoneal injection 
on day 0 and day 14, and were then exposed to nebulised 
saline solution. On the day following the final nebulization, 
invasive   plethysmography was performed, and following 
sacrifice, blood and tissue samples obtained. Twenty mice 
were used in the saline wild-type experimental group, 
n = 20 in the saline L-selectin-deficient group, n = 19 in the 
wild-type OVA group and n = 23 in the L-selectin-deficient 
OVA group.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Quantitation of serum OVA-specific  
ige levels
Serum was obtained by lethal cardiac puncture of anesthe-
tized mice and stored at −70°C for the measurement of OVA 
specific IgE. OVA specific IgE levels were determined by 
ELISA as described previously.9
Methacholine-induced airway 
hyperresponsiveness
AHR was measured by invasive plethysmography using a 
Buxco mouse plethysmograph (Buxco Electronics, Troy, 
New York). Briefly, mice were anesthetized by     intraperitoneal 
  injection of ketamine (200 µg/g) and xylazine (10 µg/g), 
tracheostomized, and the jugular vein cannulated. Mice were 
ventilated with a small animal respirator (Harvard   Apparatus, 
Holliston, MA) delivering 0.01 mL/g body weight, at a rate 
of 120 strokes/min, in a mouse plethysmograph chamber. 
  Increasing methacholine (MCh) doses were delivered 
  intravenously, and airway resistance measured (Biosystem 
XA; Buxco   Electronics) for 2 min after each dose. Results 
are expressed as the maximal resistance after each dose of 
MCh minus baseline (phosphate buffered saline – [PBS] – 
alone) resistance.
Bronchoalveolar lavage
After measurement of airway reactivity, bronchoalveolar 
lavage (BAL) was carried out, as described   previously.10 Total 
viable cell counts were determined using a   hemocytometer 
with trypan blue exclusion. Differential counts of eosinophils, 
neutrophils, lymphocytes, and monocytes/macrophages were 
determined on cytospin smears of BAL samples (4 × 105 cells) 
from individual mice stained with DiffQuick (Life Technolo-
gies, Auckland, New Zealand) after counting 300 cells.
Lung histopathology
The right lung lobes were fixed in 10% neutral buffered 
  formalin for 18–24 hours and routinely processed. Serial 5-µm 
sections taken every 100 µm were stained with   hematoxylin 
and eosin for assessment of peribronchial inflammation, with 
Masson trichrome for assessment of epithelial and subepithe-
lial collagen thickness, and Alcian blue-periodic acid Schiff 
(AB-PAS) for assessment of goblet cells.
Morphometric analysis  
of structural changes
Images of lung tissue sections were captured using a Digital 
camera (Q Imaging, Burnaby, British Columbia, Canada). 
A minimum of five bronchi measuring 150–350 µm   luminal 
diameter were analyzed per mouse for the parameters 
described below using Image Pro-Discovery software (Media 
Cybernetics, Silver Spring, MD), which was calibrated with 
a reference micrometer slide. The thickness of the bronchial 
epithelial layer was measured by tracing around the   basement 
membrane and the luminal surface of epithelial cells, and cal-
culating the area between these lines using a digitizer (Aiptek, 
Irvine, CA). Total collagen thickness was similarly measured 
by tracing around the outer extent of the total   collagen layer in 
the submucosal region and around the basement membrane, 
and the area between these lines calculated. Smooth muscle 
area was calculated by tracing around the inner and outer 
surfaces of the smooth muscle layer. Total areas were calcu-
lated by subtracting the inner area from the outer area. These 
areas were expressed per length (µm) of basement membrane 
to account for variation in bronchial diameters. Goblet cells 
were counted in AB-PAS stained sections and expressed as 
number of cells per 100 µm of basement membrane.
statistical analysis
The results were analyzed using a one-way analysis of 
variance (ANOVA); with Newman-Keuls tests for multiple 
comparisons between groups. Lung functional studies were 
analyzed with a two-way ANOVA, with Bonferroni posttest. 
In this paper P , 0.05 is described as statistically significant. 
Morphometry was expressed as median with 95% confidence 
interval and analyzed using the Mann-Whitney test.
Results
Serum OVA specific IgE levels
OVA-specific serum IgE levels of each mouse were 
  evaluated to ensure that adequate sensitisation was achieved 
(Figure 1A). OVA-specific IgE titers were significantly 
  elevated in all OVA-sensitised and challenged mice   compared 
to controls (P , 0.001). There was no significant difference 
in OVA-specific IgE levels between wildtype and L-selectin-
deficient mice groups.
Airway inflammation in allergic  
airway disease
Inflammatory responses were assessed ex vivo by performing 
differential cell counts on cells retrieved by   bronchoalveolar 
lavage (BAL). Total BAL cell counts in saline treated 
L-  selectin-deficient and wild-type mice were equivalent 
(Figure 1B). Total cell counts retrieved from the airways 
by BAL were significantly increased in wild type mice 
  following exposure to OVA (P , 0.001). Total cell counts 
in the OVA L-selectin mice were lower than in the wild-type Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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controls (P , 0.01) but still higher than the saline controls 
(P , 0.01).
Differential BAL cell counts revealed significantly 
increased numbers of eosinophils and lymphocytes in the 
OVA-treated mice and wild-type OVA mice when compared 
to saline controls (Table 1). Absence of L-selectin was not 
associated with any change in numbers of eosinophils, 
  neutrophils, and lymphocytes following OVA exposure 
when compared to wild-type mice OVA treated mice 
(Table 1).
effect of L-selectin loss on airway 
remodeling changes
OVA treatment of both wildtype and L-selectin-deficient 
mice groups resulted in significantly increased epithelial 
thickness (Figure 2A), collagen deposition in the basement 
membrane region (Figure 2B), and moderately increased 
smooth muscle thickness (Figure 2C) as compared to the 
corresponding saline wild-type and L-selectin-deficient 
controls. Representative photomicrographs are shown in 
Figures 3A–D. Goblet cell hyperplasia was also present 
in both groups of OVA mice, and not the saline treated 
mice (Figure 2D). L-selectin deficiency did not affect 
collagen thickness (Figure 2B) or goblet cell hyperplasia 
(Figure 2D) following OVA treatment compared to OVA 
treated wild-type mice. However, epithelial thickness 
(Figure 2A) and smooth muscle thickness (Figure 2C) 
were significantly decreased in L-selectin-deficient 
mice in both the saline and OVA treated groups, as com-
pared to saline and OVA treated wild-type mice respec-
tively. Representative photomicrographs are shown in 
Figures 3A–D.
effect of L-selectin on airway 
hyperresponsiveness
Airway reactivity in saline treated L-selectin-deficient mice 
was equivalent to that in saline treated wild-type mice. Airway 
reactivity was significantly higher in OVA treated wildtype 
mice compared to saline treated wild-type mice P , 0.001 at 
the highest three doses of methacholine. Lack of L-selectin 
significantly abrogated AHR due to OVA sensitization 
(Figure 4).
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Figure 1 OVA-specific IgE titers and bronchoalveolar lavage total cell counts. OVA-specific IgE titers were determined in individual serum samples by ELISA and results 
are expressed as units relative to a standard curve generated from positive control sera (arbitrary units; A). The lungs of OVA and saline-treated mice were lavaged with 
ice-cold PBs. Total cell counts were made by Trypan blue exclusion (B). Results are expressed as total cell number ×10−3 per mL BAL fluid retrieved. **P , 0.01, ***P , 0.001 
vs respective saline control, ##P , 0.01 vs respective wildtype control.
Table 1 Bronchoalveolar fluid differential cell counts
  L-selectin +/+ saline L-selectin -/- saline L-selectin +/+ OVA L-selectin -/- OVA
eosinophils 0.6212 ± 0.1414 0.1262 ± 0.08523## 3.985 ± 0.4050*** 5.094 ± 1.943**, #
neutrophils 1.180 ± 0.1794 9.094 ± 3.543 5.593 ± 0.7506*** 4.126 ± 1.217##
Monocytes 116.3 ± 11.74 140.4 ± 44.09 296.1 ± 10.51*** 206.5 ± 33.18##
Lymphocytes 13.50 ± 1.387 3.936 ± 2.072### 69.75 ± 6.425*** 46.83 ± 9.594***
Bronchoalveolar fluid differential cell counts, ±seM. *P , 0.05, **P , 0.01, ***P , 0.001 vs respective saline control, #P , 0.05, ##P , 0.01, ###P , 0.001 vs respective wildtype 
control.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Discussion
Selectin inhibition has been identified as a useful target for 
therapeutic intervention in asthma. A number of studies have 
been performed using L-selectin antagonists and antibodies 
against L-selectin, showing reduction in AHR.21,22   Likewise, 
animals deficient in L-selectin have reduced AHR.9 We 
have previously shown that mice deficient in L-selectin 
have   significantly reduced AHR but without detectable 
changes in airway inflammation.
There is evidence that airway remodeling makes an 
important contribution to AHR.23–26 As airway remodeling 
can modulate AHR independent of airway inflammation, we 
have investigated the role of L-selectin in the regulation of 
both structural remodeling and AHR in a chronic model of 
AAD.
In chronic OVA-induced models of AAD, inflamma-
tory cell infiltration is not the predominant pathological 
feature, and total numbers of inflammatory cells in BAL 
fluid and in lung tissue are much less than in acute and 
subacute AAD models.18 In the chronic AAD model, only 
a small proportion of leukocytes in the bronchoalveolar 
lavage fluid (BALF) are eosinophils, in contrast to shorter 
term models. In this study eosinophils and neutrophils 
comprised only small proportions of leukocyte numbers. 
Furthermore in L-selectin-deficient mice sensitised and 
challenged with OVA, there was no reduction in these 
individual leukocyte cell types in the BAL fluid when 
compared to wildtype controls. Although total BAL fluid 
cell numbers were decreased compared to OVA wildtype 
mice, total cell numbers were significantly greater than in 
the saline groups. As such, and given   previous findings,10 
it appears unlikely that the effect of L-selectin on inflam-
matory cell inflammation accounts directly for its effect 
on AHR.
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Figure 2 Morphometric analysis of airway wall remodeling changes. Serial sections of paraffin-embedded lung tissues stained with H&E, Masson’s trichrome, and AB-PAS 
were analyzed using image Pro-Discovery software (Media cybernetics, san Diego, california) for thickness of the epithelial (A), subepithelial collagen (B), smooth muscle 
layer (C), and number of goblet cells (D). ***P , 0.001 vs respective saline control, #P , 0.05, ##P , 0.01, ###P , 0.001 vs respective wildtype control.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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In the current study we found that L-selectin deficiency 
dramatically reduced AHR in the chronic mouse model 
of asthma. Absence of L-selectin was not associated with 
  significant reduction in influx of inflammatory cell types 
following OVA treatment, although total cell number was 
slightly reduced in the OVA treated L-selectin-deficient 
  animals as compared to OVA treated wild-type controls. 
Absence of L-selectin resulted in reduced epithelial 
  thickness and reduced smooth muscle thickness in OVA 
treated L-selectin-deficient mice as compared to OVA 
treated wild-type mice. Both of these structural changes 
have been well characterized in airway remodeling, and 
are thought to contribute to AHR in asthma. Absence 
of L-selectin had no effect on goblet cells or collagen 
deposition.
Thickening of the airway wall is likely to contribute to 
AHR as it reduces the amount of muscle contraction required 
to close the airway.12,14,27 Airway epithelial thickness has 
been shown to be significantly elevated in patients with 
severe asthma28 and in cases of fatal asthma.14,29 Epithelial 
remodeling can be promoted by a variety of causes including 
viral infection30 or eosinophilic inflammation.31 Rosen and 
colleagues found that a major ligand of L-selectin recognized 
by MECA-79 was localized to bronchial epithelial cells 
and submucosal glands in sheep.22 It is probable that these 
ligands are mucins of a type also found in the human airway 
epithelium.32,33 Reduced epithelial thickness in L-selectin-
deficient mice may be related to the absence of L-selectin 
binding to epithelial cells.
Smooth muscle thickness is also an important   feature 
of airway remodeling in asthma.34 Thickening of the 
smooth muscle bundle is due to myocyte hypertrophy 
and   hyperplasia, although there is more evidence for the 
latter. Smooth muscle cell hyperplasia may be caused by 
proliferation of myocytes, reduced apoptosis, or migra-
tion of   mesenchymal cells or circulating progenitor cells 
that   differentiate into myocytes via the fibrocyte/fibroblast 
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Figure 3 Representative photomicrographs of mouse lung stained with Masson’s 
trichrome. L-selectin +/+ saline (A), L-selectin −/− saline (B), L-selectin +/+ OVA, 
L-selectin −/− OVA. Bar = 100 µm.
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Figure 4 Airway hyperresponsiveness. Methacholine-induced AHR was measured by plethysmography 24 h after the final aerosol challenge. Results are presented as +/− 
standard deviation and expressed as the resistance change from baseline (PBs only) responses of individual mice. Two-way AnOVA with Bonferroni post-test was used to 
compare groups. **P , 0.01, ***P , 0.001 vs respective saline control, ###P , 0.001 vs respective wildtype control.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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  lineage. Loss of L-selectin may inhibit recruitment of 
stem cells that are recruited during remodeling, leading to 
increased epithelial and smooth muscle   thickness. Little is 
known of the mechanisms   regulating ontogeny of various cell 
layers in the airway wall, but it seems that loss of L-selectin 
from the surface of circulating cells may provide possible 
explanation for altered lung development in L-selectin-
deficient animals. It has been suggested that pan selectin 
antagonists may influence resident lung cell interactions, and 
have been shown to be efficacious in reducing early and late 
phase asthma response and AHR when administered in an 
inhaled form as well as intravenously.35 Further investigation 
is required into the effect of L-selectin on development at 
other organ sites and its influence on remodeling in other 
foregut-derived tissues. New functions for L-selectin are still 
being investigated, with the recent discovery that L-selectin 
is expressed on cytotrophoblasts, and interacts with ligands 
on the uterine epithelial surface.36
In the setting of airway remodeling in asthma, L-selectin 
may play a role in regulating numbers of circulating col-
lagen 1+ CD45+ and CD34+ fibrocytes in the lung. Fibro-
cytes are unique blood-borne cells with fibroblast-like 
properties.37 These cells increase in the lung after aller-
gen challenge and differentiate into collagen-producing 
myofibroblasts.38,39 They have a number of functions other 
than promoting   fibrosis. They are potent antigen present-
ing cells, and can elicit the recruitment and activation of 
T cells, as well as secrete the chemokines, cytokines, and 
growth factors that mediate fibroproliferation. There is a 
close   relationship between the numbers of fibrocytes in 
the airway, with   basement   membrane thickness. Further-
more it has been hypothesized the circulating fibrocytes 
may also be   important in contributing to other aspects 
of airway remodeling. Circulating fibrocytes have been 
shown to different into airway myofibroblasts and smooth 
muscle cells in animal models;39,40 in addition, blocking 
fibrocyte chemokine ligand CXCL12 has been shown to 
reduce fibrocyte accumulation and fibrosis in a bleomycin 
murine model.40,41
Our study indicates that L-selectin deficiency results 
in altered bronchial structure even in the saline group 
(ie,   independently of OVA induced sensitisation and 
  inflammation). This change is however undetectable by AHR in 
saline treatment mice, but may be detectable by other measures 
of baseline lung function.
Interestingly in the OVA L-selectin-deficient group, 
a   modest reduction in total inflammation and no   significant 
reduction in any individual cell type has resulted in 
  significantly reduced AHR compared to OVA treated 
  wild-type mice, and only slightly higher than the saline 
groups. Recent phase IIa trials with the pan-selectin 
antagonist bimosiamose resulted in reduced airway recruit-
ment of eosinophils in asthma patients.35 In our previous 
studies, L-selectin-deficient mice had markedly reduced 
airway hyperresponsiveness without detectable change in 
airway inflammation; however airway remodeling changes 
in epithelium and airway smooth muscle changes have been 
observed in our current chronic allergic airways disease 
model study.
The effects of L-selectin antagonists on airway remod-
eling changes in humans have not been reported, although 
the number of studies is limited. Further investigation is 
required to determine whether the findings in this mouse 
model are also evident in human asthma. As L-selectin 
inhibition is reported to reduce airway inflammation in 
humans, it is likely to have some impact on airway remod-
eling. Eosinophils promote various aspects of remodeling 
largely via cytokine production (TGFβ, IL4, IL13, VEGF, 
FGF2).42 Neutrophils also contribute to remodeling through 
the effects of neutrophil elastases, which cause mucous cell 
hypertrophy and hyperplasia,43 and stimulate expression of 
mucin genes.44 Cytokines produced by Th2 lymphocytes 
have multiple pro-remodeling effects,45 while mast cell 
tryptases stimulate myocyte proliferation.46 Airway inflam-
mation may also result in airway remodeling by alterna-
tive pathways such as response to epithelial damage47 as 
structural changes are present in the airways of children 
before asthma symptoms.48
Conclusion
In summary, the relative contributions of airway   inflammation 
and airway remodeling to airway hyperresponsiveness 
remains complex and controversial. New treatments for 
severe asthma must preferably have combined effects on 
  airway inflammation and airway remodeling, as well as 
airway   hyperresponsiveness. Our findings further support 
L-selectin as a potential target for asthma therapeutics, 
with dramatic effects on airway hyperresponsiveness and 
remodeling.
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